Dr. Fanger has over 20 years of experience in the life sciences industry, spanning business development, product strategy, and biological research. Previously, he co-founded Teranode Corporation (acquired by Rage Frameworks, Inc., which was acquired by Genpac (NYSE:G)), where he led teams that introduced new AI and software automation products into the marketplace. He was responsible for securing worldwide partnerships with strategic customers such as Daiichi Sankyo, Grünenthal GmbH, Pfizer, AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline. Prior, Dr. Fanger held scientist positions at Corixa Corporation (acquired by GSK) and Immunex Corporation (acquired by Amgen). Dr. Fanger serves as the Chairman of Rise Therapeutics and a scientific director of Celdara and MBV. He is co-inventor on several patents covering novel biological therapeutics and software technologies, and co-author on numerous research publications in leading scientific journals. Dr. Fanger graduated from Denison University with a BS in chemistry and Dartmouth Medical School with a PhD in physiology.
Neil Fanger, PhD | President & CEO
